Penumbra (NYSE:PEN) announced additional results from its STORM-PE trial of computer-assisted vacuum thrombectomy (CAVT).
Notícias ao Minuto on MSN
Penumbra study backs mechanical thrombectomy for treating pulmonary embolism
The study found that the use of the company’s computer-assisted vacuum thrombectomy (CAVT) system, a form of mechanical ...
Penumbra Inc. (($PEN)) announced an update on their ongoing clinical study. Study Overview: Penumbra Inc. is conducting a study titled ‘BOLT: A ...
IRVINE, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and ...
Lightning Flash™ is the most advanced mechanical thrombectomy system on the market to address venous and pulmonary thrombus Next generation technology combines superior catheter design with the latest ...
Deep vein thrombosis (DVT) is a significant health problem, leading to the hospital admission of over 250,000 Americans each year. Its most serious acute complication, namely pulmonary embolus, kills ...
Editor’s note: This article contains a photo of a blood clot that some viewers may find disturbing. GRAND RAPIDS, Mich. (WOOD) — Corewell Heath Butterworth Hospital is being recognized for its work ...
2don MSN
General anesthesia during clot-removal surgery leads to better neurological outcomes at 3 months
Patients who undergo general anesthesia while receiving a specialized surgery to treat strokes have better outcomes than ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback